Head and Neck Tumor Immunology

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Cancer treatment and research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-1-4613-1499-8_15
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• An immunologic profile of young adults with head and neck cancer

  1989cited by this paper
• Incidence of serum antibody reactivity to autologous head and neck cancer cell lines and augmentation of antibody reactivity following acid dissociation and ultrafiltration.

  1989cited by this paper
• Selective killing of squamous carcinoma cells by an immunotoxin that recognizes the egf receptor

  1989cited by this paper
• Biological response modifiers: the new immunotherapy.

  1989cited by this paper
• Immunologic determinants of head and neck cancer response to induction chemotherapy.

  1989cited by this paper
• Targeting of cancer with radiolabeled antibodies. Prospects for imaging and therapy.

  1988cited by this paper
• Human squamous cell carcinoma lines express oncofetal 44‐kd polypeptide defined by monoclonal antibody to mouse fetus

  1988cited by this paper
• Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity.

  1988cited by this paper
• THE RELATIONSHIP OF CIRCULATING IgA TO CELLULAR IMMUNITY IN HEAD AND NECK CANCER PATIENTS

  1988cited by this paper
• Hormone conjugated with antibody to CD3 mediates cytotoxic T cell lysis of human melanoma cells.

  1988cited by this paper
• Mechanism of Complement Activation After Coronary Artery Occlusion: Evidence That Myocardial Ischemia in Dogs Causes Release of Constituents of Myocardial Subcellular Origin That Complex With Human C1q In Vivo

  1988cited by this paper
• Association of levels of circulating C1q binding macromolecules with induction chemotherapy response in head and neck cancer patients.

  1988cited by this paper
• Redesigning nature's poisons to create anti-tumor reagents.

  1987cited by this paper
• Reactivity of monoclonal antibody 17.13. with human squamous cell carcinoma and its application to tumor diagnosis.

  1987cited by this paper
• An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck.

  1987cited by this paper
• Circulating IgA immune complexes in head and neck cancer, nasopharyngeal carcinoma, lung cancer, and colon cancer

  1987cited by this paper
• Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo.

  1987cited by this paper
• Possible role of anti-idiotypic antibodies in the induction of tumor immunity.

  1987cited by this paper
• Immunoregulation by antigen/antibody complexes. I. Specific immunosuppression induced in vivo with immune complexes formed in antibody excess.

  1987cited by this paper
• Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy

  1986cited by this paper
• Immune complexes, serum proteins, cell‐mediated immunity, and immune regulation in patients with squamous cell carcinoma of the head and neck

  1986cited by this paper
• Detection of circulating immune complexes in patients with squamous cell carcinoma of the oral cavity.

  1986cited by this paper
• Differential effects of recombinant human leukocyte interferons on cell surface antigen expression.

  1986cited by this paper
• Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF).

  1986cited by this paper
• Selective Killing of Laryngeal Carcinoma Cells by a Monoclonal Immunotoxin

  1986cited by this paper
• Inhibition of Natural Killer Cell Activity by Antigen‐Antibody Complexes

  1986cited by this paper
• Basic principles and applications of monoclonal antibodies in the management of carcinomas: the Richard and Hinda Rosenthal Foundation award lecture.

  1986cited by this paper
• Cell‐mediated immune status in patients with squamous cell carcinoma of the oral cavity

  1985cited by this paper
• Non-Immunological Factors Affecting the Localization of Monoclonal Antibodies in Xenografts of Human Breast and Colon Tumors

  1985cited by this paper
• Blocking (suppressor) factors, immune complexes, and extracorporeal immunoadsorption in tumor immunity.

  1985cited by this paper
• Human Immune Responses to Murine Monoclonal Antibodies

  1985cited by this paper
• Papillomavirus DNA in human tongue carcinomas

  1985cited by this paper
• Effect of immune complexes from mastitic milk on blocking of Fc receptors and phagocytosis

  1985cited by this paper
• The pathophysiology of circulating immune complexes: their role in host-tumor interactions and removal by immunoadsorption therapy.

  1985cited by this paper
• Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.

  1985cited by this paper
• Circulating immunocomplexes and laryngeal carcinoma.

  1985cited by this paper
• Transfectomas provide novel chimeric antibodies.

  1985cited by this paper
• Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments.

  1984cited by this paper
• Induction of immunity to a human tumor marker by in vivo administration of anti-idiotypic antibodies in mice.

  1984cited by this paper
• From an Antigen‐Centered, Clonal Perspective of Immune Responses to an Organism‐Centered, Network Perspective of Autonomous Activity in a Self‐Referential Immune System

  1984cited by this paper
• Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.

  1984cited by this paper
• Altered tumor growth in vivo after immunization of mice with antitumor antibodies.

  1984cited by this paper
• Immunological characterization of FcR gamma bearing and nonbearing B cells: functional modulation of immune complexes.

  1984cited by this paper
• Modulation of human B cell immunoglobulin secretion by the C3b component of complement.

  1984cited by this paper
• 1984: All Idiotypes are Equal, But Some are More Equal Than Others

  1984cited by this paper
• Idiotypic Networks and Other Preconceived Ideas

  1984cited by this paper
• Suppression of polyclonal human B cell activation by IgG binding factors: interference with the maturation of Ig-containing cells into Ig-secreting cells.

  1984cited by this paper
• Circulating immune complexes in sera of patients with oral cancer.

  1984cited by this paper
• Some thoughts on the biologic role of immunoglobulin A.

  1983cited by this paper
• Modulation of Fc receptors of mononuclear phagocytes by immobilized antigen-antibody complexes. Quantitative analysis of the relationship between ligand number and Fc receptor response

  1983cited by this paper
• Abnormal interferon modulation of natural cytotoxicity in systemic lupus erythematosus. Relation to suppressive serum factors.

  1983cited by this paper
• Inhibition of complement-dependent phagocytosis by monocytes following pre-incubation with immune complexes and interaction with plasma.

  1983cited by this paper
• Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation.

  1983cited by this paper
• Elevated Serum Secretory Immunoglobulin a Levels in Patients with Head and Neck Carcinoma

  1983cited by this paper
• Immunobiologic Staging of Patients with Carcinoma of the Head and Neck

  1983cited by this paper
• PERIPHERAL K CELLS IN GRAVES’DISEASE AND HASHIMOTO'S THYROIDITIS IN RELATION TO CIRCULATING IMMUNE COMPLEXES

  1983cited by this paper
• BIOLOGIC FUNCTION OF THE SERUM IgA SYSTEM: MODULATION OF COMPLEMENT‐MEDIATED EFFECTOR MECHANISMS AND CONSERVATION OF ANTIGENIC MASS *

  1983cited by this paper
• Monoclonal SBF produced by a hybridoma: in-vitro and in-vivo suppression of B tumour-cell proliferation.

  1983cited by this paper
• Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens.

  1983cited by this paper
• Feedback regulation of immune responses by immune complexes; possible involvement of a suppressive lymphokine by FcR gamma-bearing B cell.

  1982cited by this paper
• Depression of natural killer cell activity by syphilitic serum and immune complexes.

  1982cited by this paper
• Effect of sera from patients with rheumatoid arthritis on normal lymphocytes: a possible immunoregulatory role for immune complexes.

  1982cited by this paper
• Characterization and Function of T Cell Fcγ Receptor

  1981cited by this paper
• Loss of suppressor T cell function and circulating immune complexes in chronic active liver diseases.

  1981cited by this paper
• Natural cytotoxicity in rheumatoid arthritis and systemic lupus erythematosus.

  1981cited by this paper
• Role of serum IgA. Hepatobiliary transport of circulating antigen

  1981cited by this paper
• Production of predominantly polymeric IgA by human peripheral blood lymphocytes stimulated in vitro with mitogens

  1980cited by this paper
• Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen.

  1980cited by this paper
• Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells.

  1980cited by this paper
• The ability of IgA to inhibit the complement-mediated lysis of target red blood cells sensitized with IgG antibody.

  1980cited by this paper
• Blocking factors in sera of breast cancer patients

  1979cited by this paper
• Insoluble immune complexes suppress mitogen-induced proliferation of human T lymphocytes bearing Fc gamma receptors.

  1979cited by this paper
• Specific in vivo inhibition of macrophage receptors for cytophilic antibody by soluble immune complexes.

  1979cited by this paper
• Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck. Preliminary assessment of an intensive drug regimen

  1979cited by this paper
• Oral cancer and herpes simplex virus--a review.

  1979cited by this paper
• Inhibition of leukocyte migration by tumor-associated antigen and its modification by serum; IgA as a blocking factor.

  1978cited by this paper
• Suppression by IgA of IgG-mediated phagocytosis by human polymorphonuclear leucocytes.

  1978cited by this paper
• Soluble Immune Complexes in Sera from Head and Neck Cancer Patients: A Preliminary Report

  1978cited by this paper
• Direct blockade of antigen-reactive B lymphocytes by immune complexes. An 'off' signal for precursors of IgM-producing cells provided by the linkage of antigen-and Fc-receptors.

  1978cited by this paper
• Demonstration of immunoglobulin in tumor and marginal tissues of squamous cell carcinomas of the head and neck.

  1977cited by this paper
• Induction of tolerance after oral feeding of soluble protein antigen [proceedings].

  1977cited by this paper
• Inhibition of homocytotropic antibody responses in adult inbred mice by previous feeding of the specific antigen.

  1977cited by this paper
• Plasmapheresis in patients with disseminated cancer: Clinical results and correlation with changes in serum protein. The concept of “nonspecific blocking factors”

  1977cited by this paper
• Detection and localization of tumor-associated immune components of head and neck squamous cell carcinomas.

  1976cited by this paper
• Synergism between immune complexes and serum from tumor-bearing mice in the suppression of mitogen responses.

  1976cited by this paper
• Circulating immune complexes in sera of patients with Burkitt's lymphoma and nasopharyngeal carcinoma

  1976cited by this paper
• Bactericidal activity of meningococcal antisera. Blocking by IgA of lytic antibody in human convalescent sera.

  1975cited by this paper
• Blocking of spleen cell activity against target mammary tumor cells by viral antigens.

  1975cited by this paper
• Suppression of in vitro antibody synthesis by immunoglobulin-binding factor

  1975cited by this paper
• Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.

  1975cited by this paper
• The association of the IgA levels of serum and whole saliva with the progression of oral cancer

  1975cited by this paper
• Continuous cultures of fused cells secreting antibody of predefined specificity

  1975cited by this paper
• IgA as a blocking factor in human malignant melanoma.

  1974cited by this paper
• Speculations on idiotypes and homobodies.

  1973cited by this paper
• Elution of “blocking factors” from human tumors, capable of abrogating tumor‐cell destruction by specifically immune lymphocytes

  1972cited by this paper
• Serum concentrations of G, A, and M immunoglobulins in patients with carcinoma, melanoma, and sarcoma.

  1971cited by this paper
• Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.

  1971cited by this paper
• The Collected Papers of Paul Ehrlich

  1957cited by this paper

• IgA and Cancer

  2000cites this paper
• Interleukin-1 regulates interleukin-6 secretion in human oral squamous cell carcinoma in vitro: possible influence of p53 but not human papillomavirus E6/E7.

  1998cites this paper
• Immunology of Head and Neck Cancer

  1995cites this paper
• Second Primary Malignancies in the Head and Neck Cancer Patient

  1995cites this paper
• Grundlagen immunologischer Vorgänge beim Plattenepithelkarzinom im Kopf-Hals-Bereich — Diagnostik und Ursachen

  1995cites this paper
• Cytokine Synergy in Immunotherapy

  1993cites this paper
• Role of Immune Response in the Prognosis of Carcinoma of the Uterine Cervix: Can in Vitro Analysis Provide a better Framework for more Effective Management?

  1992cites this paper
• Interleukin 2 Receptor Expression in Patients With Head and Neck Squamous Carcinoma: Effects of Thymosin α1 In Vitro

  1989cites this paper